UPDATE 1-Athersys stem-cell therapy for bowel disease fails in trial – Reuters
UPDATE 1-Athersys stem–cell therapy for bowel disease fails in trialReutersThe stem–cell therapy, known as MultiStem, is derived from adult bone marrow or other tissue sources and is designed to reduce inflammation and protect and heal damaged tissue. MultiStem was being tested in patients with ulcerative colitis who have …Athersys Inc. stem cell therapy for bowel … Continue reading
